Novel use of salvia root extract
A technology for extracts and uses, applied in the field of new uses of salvia miltiorrhiza extracts, can solve problems such as less research
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0040] The preparation method of Salvia miltiorrhiza extract can adopt the method known to those skilled in the art, such as the method of extracting from plants, or the method of chemical synthesis. Preferably, the method of direct extraction from plants can be used.
[0041] use
[0042] The present invention provides the use of salvia miltiorrhiza extract for preparing a composition for reducing the formation of myocardial vacuoles.
[0043] Myocardial vacuolation is a factor that produces myocardial damage, which is caused by protein degradation. The salvia miltiorrhiza extract described herein can prevent the formation of myocardial vacuoles to avoid myocardial damage or alleviate the degree of myocardial damage.
[0044] In addition, the salvia miltiorrhiza extract can also be used for: inhibiting the weight loss of mammals caused by doxorubicin; inhibiting the weight loss of mammalian hearts; improving mammalian bradycardia; or reducing the content of creatine kinase, ...
Embodiment 1
[0067] Protective effect of salvianolic acid on doxorubicin-induced cardiotoxicity in mice
[0068] In this example, the cardioprotective effect of salvianolic acid was studied.
[0069] animal
[0070] Clean grade KM mice, body weight 20g±2, male. Purchased from Shanghai Laboratory Animal Center, Chinese Academy of Sciences.
[0071] reagent
[0072] Salvianolic acid (SA) extraction method: 100-mesh salvia powder sample (purchased from Pingyi Salvia plantation base, Shandong) 30g, dissolved in 70% ethanol (1000ml), refluxed for 1 hour, and the extraction amount was determined by weight loss method.
[0073] Identification of salvianolic acid: The extract was filtered with a 0.45 μm microporous membrane, and identified by Agilent 1100 HPLCsystem (Agilent Technologies, Palo Alto, CA, USA). The obtained liquid chromatogram is shown in figure 1 shown.
[0074] Doxorubicin (doxorubicin hydrochloride for injection): purchased from Zhejiang Hisun Pharmaceutical Co., Ltd., batch...
Embodiment 2
[0093] Protective effect of tanshinone IIA sodium sulfonate injection on doxorubicin-induced cardiotoxicity in mice
[0094] In this example, the cardioprotective effect of tanshinone IIA sodium sulfonate injection was studied.
[0095] animal
[0096] Clean grade KM mice, body weight 20g±2, male. Purchased from Shanghai Laboratory Animal Center, Chinese Academy of Sciences.
[0097] reagent
[0098] Tanshinone IIA Sodium Sulfonate Injection: purchased from Shanghai No. 1 Biochemical Pharmaceutical Co., Ltd., batch number 070701.
[0099] Doxorubicin (doxorubicin hydrochloride for injection): purchased from Zhejiang Hisun Pharmaceutical Co., Ltd., batch number 061102.
[0100] experimental method
[0101] Fifty-four KM mice, weighing 20g ± 2g, male, were randomly divided into four groups after being adapted to feeding for 3 days:
[0102] Normal group (Control, n=13);
[0103] Doxorubicin group (DXR, n=15);
[0104] 5mg / kg tanshinone IIA sodium sulfonate group (low dos...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com